Skip to main content
. 2010 Sep 1;7(5):300–308. doi: 10.7150/ijms.7.300

Table 2.

Characteristics of published studies on GSTP1I le105Val included in the meta-analysis

Author (ref*) Year Origin Ethnicity SNPsite Sample size(case/control) HWE MAF in controls Genotypic ORs& Power (%) †
homozygotes/heterozygotes OR>1.5 OR>2.0
Lin DX&28 1998 China Asian GSTP1 Ile105Val 42/36 0.359 0.24 0.25/0.83 12.3 28.9
Morita S29 1998 Japan Asian GSTP1 Ile106Val 66/164 0.412 0.16 0.26/0.19 19.2 49.2
van Lieshout EM30 1999 The Netherlands Caucasian GSTP1 Ile107Val 34/247 0.739 0.23 3.65/3.44 16.4 40.7
Tan W&31 2000 China Asian GSTP1 Ile108Val 150/150 0.616 0.22 1.47/0.89 33.5 77.1
Lee JM22 2000 China(Taiwan) Asian GSTP1 Ile109Val 90/254 NA# NA# NA#/ NA# NA# NA#
Casson AG21 2003 Canada Caucasian GSTP1 Ile110Val 45/45 0.019 0.29 0.78/2.51 14.6 35.1
Roth MJ32 2004 China Asian GSTP1 Ile111Val 131/454 0.057 0.22 0.79/0.88 43.0 88.2
Casson AG20 2006 Canada Caucasian GSTP1 Ile112Val 56/95 0.834 0.35 2.22/1.36 21.7 52.7
Cai L25 2006 China Asian GSTP1 Ile113Val 204/393 0.872 0.18 0.46/0.93 48.4 92.6
Murphy SJ33 2007 Irish Caucasian GSTP1 Ile114Val 207/223 0.201 0.36 0.99/0.93 54.0 94.4
Canova C19 2009 European Caucasian GSTP1 Ile115Val 1471/1405 0.330 0.32 0.97/1.13 99.9 100.0

* The ref was referred to the reference numbers in this study.

& data from the same source, so selected by the latest sample size.

# NA: Not available.

&Genotypic odds ratios for homozygotes and heterozygotes.

Power was calculated by the DSTPLAN4.2 software with MAF in controls as the frequency of risk factor, OR was selected 1.5 and 2.0 as the relative risk and а=0.05 as the significance.